SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Roger Cranwill who wrote (784)5/1/1997 11:53:00 AM
From: I. Luttichuys   of 1762
 
Roger, That is a very interesting question. I have just begun hearing things about Oxandrin as it applies to patients at St. Vincent's and have barely scratched the surface on checking into this myself. I would have to say that, intuitively it certainly could be a possibility but for the FDA to act in such a way I would guess that first, this kind of abuse problem would have to develop. Whether there is something about the drug that would make that kind of abuse unlikely among individuals interested in that sort of thing, I do not yet know. For example I do not know how the effects of this drug compare with the more commonly abused steroid drugs.
I do not think such abuse would put this on the same sort of Schedule as say, pharmaceutical cocaine. That is the kind of thing one wouldn't want to see as then many docs may consciously seek alternative drugs. I don't think that kind of thing would be likely here. I think you'd have to have quite an abuse problem develop to see this kind of FDA reaction. I suppose that I am giving an answer to you question which is no more an educated guess at this point that this concern is probably not serious although I'm about where you are on this company and drug so far.
BENNETT
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News